We manufacture your vectors in FDA-compliant gene therapy labs using validated processes. Our facility is specifically designed to expedite your gene therapy development.
From the site, we deliver a full spectrum of complementary viral vector process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research-grade and preclinical vector production, and analytical assay testing and validation.
Recombinant Competent Lentivirus (RCL) testing (extended and qPCR), vector stability testing, and safety and sterility testing are available.
Our expert team leverages powerful and state of the art technologies to accelerate your cell and gene therapy so you can meet the standards of today and prepare for the future. With deep expertise in early phase development and manufacturing, we can provide you with cost-appropriate services, making viral vector production accessible.
Genezen provides exceptional customer service and contracting to facilitate access to academic core resources and talent. Together with our in-house capabilities, they expand the contract laboratory and storage facility services we provide.
We can transduce the following cell type:
We offer more-than-minimally manipulated cell and tissue procedures performed aseptically in the cleanroom in accordance with GMP / GTP quality compliance requirements. Our cell manufacturing services encompass:
Our partnership with Indiana University and its Gene Therapy Testing Laboratory increases our capacity for high-quality clinical trial subject sample testing and release testing services, including: